All posts tagged "vitoss"

  • Biologics
    Orthovita Gets FDA Clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute

    Orthovita, Inc., an orthobiologics and biosurgery company, said that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities. In a release, the Company noted: Orthovita...

  • Biologics
    Orthovita Receives FDA Clearance for Vitoss™ Bioactive Foam-2X Bone Graft Substitute

    MALVERN, Pa.–(BUSINESS WIRE)–Orthovita, Inc. (NASDAQ: VITA), an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities. Orthovita expects...

OrthoSpineNews is a publication run by Ortho Spine Companies which includes other brands like The De Angelis Group, Ortho Sales Partners, OrthoEx and Surg.io

Our desire is to provide valuable content to the industry we love in an easy to read manner.

Copyright © 2018 OrthoSpineNews.

Themed By teapots